Home⇛The PCMC Journal⇛vol. 21 no. 1 (2025)

Clinical profile, management and outcome of patients diagnosed with Bronchiectasis enrolled in the Chronic Lung Disease Program in a tertiary pediatric hospital from 2021-2023

Jenni Rose D. Dimacali

Discipline: medicine by specialism

 

Abstract:

OBJECTIVE: To describe bronchiectasis profiles at the Philippine Children’s Medical Center (2021-2023). MATERIALS AND METHODS: A retrospective chart review at PCMC analyzed the demographic profile, imaging, management and outcome of patients with bronchiectasis enrolled in the Chronic Lung Disease Program from 2021-2023. RESULTS: Twenty seven patients were included in this study. Most patients were diagnosed after the age of six and showed female predominance. The most common symptom at the time of diagnosis was chronic cough (81.5%) with pulmonary tuberculosis (51.9%) as the most common etiology. All patients were treated with cyclic azithromycin. Pseudomonas aeruginosa was the prevalent microorganism isolated in the sputum and tracheal aspirate samples of the patients (56.5%). CONCLUSION: Patients with bronchiectasis were more commonly diagnosed in children past age of six with more prevalence in females. The most common symptom was chronic cough followed by fever, dyspnea and weight loss. Pulmonary tuberculosis and recurrent respiratory infections were noted to be the most common etiology with the left lower lobe most affected in HRCT. The most common phenotype seen was cystic, which is irreversible and a sign of progressive bronchiectasis, which may point to a late diagnosis. This emphasizes the need for physicians to have a high index of suspicion in patients with chronic or recurrent respiratory symptoms. All patients were treated with an oral macrolide with 25-31% of patients with decreased and/or absent symptoms. Pseudomonas aeruginosa was the prevalent microorganism isolated in the sputum and tracheal aspirate samples of the patients, which should be taken into account when treating for exacerbation.



References:

  1. Chang AB, Fortescue R, Grimwood K, Alexopoulou E, Bell L, Boyd J, Bush A, Chalmers JD, Hill AT, Karadag B, Midulla F, McCallum GB, Powell Z, Snijders D, Song WJ, Tonia T, Wilson C, Zacharasiewicz A, Kantar A. European Respiratory Society guidelines for the management of children and                adolescents with bronchiectasis. Eur Respir J [Internet]. 2021 Feb 4 [cited 2024 Oct 9]; 58(2):2002990. Available from: https://doi.org/10.1183/13993003.02990-2020
  2. Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet [Internet]. 2018 Sep [cited 2024 Oct 9]; 392(10150):880-90. Available from: https://doi.org/10.1016/s0140-6736(18)31767-7
  3.  Goyal V, Chang A. Bronchiectasis in children: Pathophysiology and causes [Internet]. [cited 2024 May 10]. Available from: https://www.uptodate.com/contents/causes-of-bronchiectasis-in-children
  4. Philippine Pediatric Society Data Registry [Internet]. [Cited 2024 May 10]. Available from: https://pps.ivant.com/search.do
  5. Gong T, Wang X, Li S, Zhong L, Zhu L, Luo T, Tian D. Global research status and trends of bronchiectasis in children from 2003 to 2022: A 20-year bibliometric analysis. Front Pediatr [Internet]. 2023 Feb 3 [cited 2024 Oct 9];11. Available from: https://doi.org/10.3389/fped.2023.1095452
  6. Brower KS, Del Vecchio MT, Aronoff SC. The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects. BMC Pediatr [Internet]. 2014 Dec [cited 2024 Oct 9]; 14(1). Available from: https://doi.org/10.1186/s12887-014-0299-y
  7. Lee E, Shim JY, Kim HY, Suh DI, Choi YJ, Han MY, Baek KS, Kwon JW, Cho J, Jung M, Kim YS, Sol IS, Kim BS, Chung EH, Lee S, Jeong K, Jang YY, Jang GC, Hyun MC, Yang HJ, Shin M, Kim JT, Kim JH, Hwang YH, Ahn JY, Seo JH, Jung JA, Kim HS, Oh MY, Park Y, Lee MH, Lee SY, Jung S, Hong SJ, Ahn YM. Clinical characteristics and etiologies of bronchiectasis in Korean children: A multicenter retrospective study. Respir Med [Internet]. 2019 Apr [cited 2024 Oct 9]; 150:8-14. Available from: https://doi.org/10.1016/j.rmed.2019.01.018
  8. Kumar A, Lodha R, Kumar P, Kabra SK. Non-cystic fibrosis bronchiectasis in children: Clinical profile, etiology and outcome. Indian Pediatr [Internet]. 2015 Jan [cited 2024 Oct 9]; 52(1):35-7. Available from: https://doi.org/10.1007/s13312-015-0563-8
  9. Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, Tjhung I, Hare KM, Ware RS, Chang AB. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med [Internet]. 2013 Oct [cited 2024 Oct 9]; 1(8):610-20. Available from: https://doi.org/10.1016/s2213-2600(13)70185-1
  10. Gaillard EA, Carty H, Heaf D, Smyth RL. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol [Internet]. 2003 Sep [cited 2024 Oct 9]; 47(3):215-20. Available from: https://doi.org/10.1016/  s0720-048x(02)00122-5
  11. Chang AB, Redding GJ. Kendig’s Disorders of the Respiratory Tract in Children [Internet]. [place unknown]: Elsevier; 2019. Bronchiectasis and Chronic Suppurative Lung Disease; [cited 2024 Oct 9]; p. 439-59. Available from: https://doi.org/10.1016/b978-0-323-44887-1.00026-2
  12.  Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Lancet [Internet]. 2018 Sep [cited 2024 Oct 9]; 392(10150):866-79. Available from: https://doi.org/10.1016/s0140-6736(18)31554-x
  13.   King P. The pathophysiology of bronchiectasis. Int J Chronic Obstr Pulm Dis [Internet]. 2009 Oct [cited 2024 Oct 9]:411. Available from: https://doi.org/10.2147/copd.s6133
  14. Reid LM. Reduction in Bronchial Subdivision in Bronchiectasis. Thorax [Internet]. 1950 Sep 1 [cited 2024 Oct 9]; 5(3):233-47. Available from: https://doi.org/10.1136/thx.5.3.233
  15. Kucuk C, Turkkani MH, Arda K. A case report of reversible bronchiectasis in an adult: Pseudobronchiectasis. Respir Med Case Rep [Internet]. 2019 [cited 2024 Oct 9]; 26:315-6. Available from: https://doi.org/10.1016/j.rmcr.2019.03.002
  16. Schäfer J, Griese M, Chandrasekaran R, Chotirmall SH, Hartl D. Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis. BMC Pulm Med [Internet]. 2018 May 22 [cited 2024 Oct 9]; 18(1). Available from: https://doi.org/10.1186/s12890-018-0630-8
  17. Kim HY, Kwon JW, Seo J, Song YH, Kim BJ, Yu J, Hong SJ. Bronchiectasis in Children: 10-Year Experience at a Single Institution. Allergy Asthma Immunol Res [Internet]. 2011 [cited 2024 Oct 9]; 3(1):39. Available from: https://doi.org/10.4168/aair.2011.3.1.39
  18. A Case Report of the First Filipino Infant Diagnosed with Cystic Fibrosis through the Philippine Newborn                 Screening Program. Acta Medica Philipp [Internet]. 2023 [cited 2024 Oct 9]. Available from: https://doi.org/10.47895/amp.vi0.7570
  19. Goyal V, Grimwood K, Marchant J, Masters IB, Chang AB. Does failed chronic wet cough response to                 antibiotics predict bronchiectasis? Arch Dis Child [Internet]. 2014 Feb 12 [cited 2024 Oct 9];99(6):522-5. Available from: https://doi.org/10.1136/archdischild-2013-304793
  20. Wurzel DF, Marchant JM, Yerkovich ST, Upham JW, Petsky HL, Smith-Vaughan H, Masters B, Buntain H, Chang AB. Protracted Bacterial Bronchitis in Children. Chest [Internet]. 2016 Nov [cited 2024 Oct 9]; 150(5):1101-8. Available from: https://doi.org/10.1016/j.chest.2016.06.030
  21. Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Lancet [Internet]. 2018 Sep [cited 2024 Oct 9]; 392(10150):866-79. Available from: https://doi.org/10.1016/s0140-6736(18)31554-x
  22. Goyal V, Chang A. Bronchiectasis in children without cystic fibrosis: Management. [cited 2024 May 10]. Available from: https://www.uptodate.com/contents/management-of-bronchiectasis-in-children-without-cystic-fibrosis
  23. Qin L, Gonçalves-Carvalho F, Xia Y, Zha J, Admetlló M, Maiques JM, Esteban-Cucó S, Duran X, Marín A, Barreiro E. Profile of Clinical and Analytical Parameters in Bronchiectasis Patients during the COVID-19 Pandemic: A One-Year Follow-Up Pilot Study. J Clin Med [Internet]. 2022 Mar 21 [cited 2024 Oct 9]; 11(6):1727. Available from: https://doi.org/10.3390/jcm11061727
  24. Öcal S, Portakal O, Öcal A, Demir AU, Topeli A, Çöplü L. Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects. Respir Med [Internet]. 2016 Oct [cited 2024 Oct 9]; 119:109-14. Available from: https://doi.org/10.1016/j.rmed.2016.08.027
  25. Kawi J, Fudolig M, Serafica R, Reyes AT, Sy F, Leyva EW, Evangelista LS. Health information sources and health‐seeking behaviours of Filipinos living in medically underserved communities: Empirical quantitative research. Nurs Open [Internet]. 2024 Mar [cited 2024 Oct 10]; 11(3). Available from: https://doi.org/10.1002/nop2.2140
  26. Berkman LF, Kawachi I, eds. Social Epidemiology. Oxford University Press; 2000.
  27. Flores G. Language barriers to health care in the United States. N Engl J Med. 2006; 355(3):229-231. doi:10.1056/NEJMp06804

Tools


Copyright © 2025  KITE Digital Educational Solutions |  Exclusively distributed by CE-Logic